CI_with
has_DoseForm
has_Ingredient
has_MoA
has_PE
may_treat
drug associated with AE
Cellular or Molecular Interactions [MoA]
Drug Hypersensitivity [Disease/Finding]
Hypercholesterolemia [Disease/Finding]
Hyperlipoproteinemia Type II [Disease/Finding]
Decreased Cholesterol Absorption [PE]
ezetimibe [Chemical/Ingredient]
[CV350] ANTILIPEMIC AGENTS
Oral Tablet [Dose Form]
EZETIMIBE
EZETIMIBE 10MG TAB [VA Product]
EZETIMIBE TAB
N0000164051
C40930
<Product_Component>EZETIMIBE</Product_Component><Strength>10</Strength><Unit>MG</Unit><VA.IEN>4040</VA.IEN>
VA Product
0
4016366
10
349556
C1165147
ezetimibe 10 MG Oral Tablet
EZETIMIBE 10MG TAB
依折麦布片(进口)
EZETIMIBE 10MG TAB
MG
<VANDF_Record>50.68^16003^Active/Master</VANDF_Record><VA_File>50.68</VA_File><VA_IEN>16003</VA_IEN><VA_Status>Active/Master</VA_Status>
fatigue AE
abdominal distension AE
alanine aminotransferase level increased AE
myalgia AE
headache AE
abdominal pain AE
nausea AE
constipation AE
diarrhea AE
aspartate aminotransferase level increased AE
clinically significant rise of serum transaminase AE
EZETIMIBE 10MG TAB [VA Product]
EZETIMIBE TAB
N0000164051
C40930
349556
<Product_Component>EZETIMIBE</Product_Component><Strength>10</Strength><Unit>MG</Unit><VA.IEN>4040</VA.IEN>
VA Product
4016366
0
C1165147
ezetimibe 10 MG Oral Tablet
EZETIMIBE 10MG TAB
依折麦布片(进口)
EZETIMIBE 10MG TAB
10
MG
<VANDF_Record>50.68^16003^Active/Master</VANDF_Record><VA_File>50.68</VA_File><VA_IEN>16003</VA_IEN><VA_Status>Active/Master</VA_Status>